Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atacicept in Optic Neuritis (CIS)
NCT00624468Phase 2Terminated
- Sponsor
- EMD Serono
- Start
- Jun 2008
- Primary completion
- Sep 2009
- Modality
- Fc-Fusion Proteins
- Countries
- 11
01
Overview
A Phase 2 trial of atacicept in optic neuritis (ON), sponsored by EMD Serono. Started Jun 2008; status: terminated.
02
Drugs
atacicept
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on NCT00624468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00624468.